世界の遺伝性トランスサイレチンアミロイドーシス(HATTR)市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4310 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、遺伝性トランスサイレチンアミロイドーシス(HATTR)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、皮下注射、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の市場動向 ・企業の競争状況、市場シェア ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の種類別市場規模と予測2016-2027（経口、皮下注射、その他） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の用途別市場規模と予測2016-2027（病院、診療所、その他） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝性トランスサイレチンアミロイドーシス(HATTR)の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Alnylam Pharmaceuticals、Akcea Therapeutics、Prothena、Lonis Pharmaceuticals、Eidos Therapeutics、Corino Therapeutics Inc） ・結論

Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.

Market Analysis and Insights: Global Hereditary Transthyretin Amyloidosis (HATTR) Market
The global Hereditary Transthyretin Amyloidosis (HATTR) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hereditary Transthyretin Amyloidosis (HATTR) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hereditary Transthyretin Amyloidosis (HATTR) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hereditary Transthyretin Amyloidosis (HATTR) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hereditary Transthyretin Amyloidosis (HATTR) market.

Global Hereditary Transthyretin Amyloidosis (HATTR) Scope and Market Size
Hereditary Transthyretin Amyloidosis (HATTR) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Transthyretin Amyloidosis (HATTR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Subcutaneous Injection
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Subcutaneous Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Perspective (2016-2027)
2.2 Hereditary Transthyretin Amyloidosis (HATTR) Growth Trends by Regions
2.2.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Share by Regions (2016-2021)
2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Regions (2022-2027)
2.3 Hereditary Transthyretin Amyloidosis (HATTR) Industry Dynamic
2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
2.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
2.3.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue
3.1.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue (2016-2021)
3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2016-2021)
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hereditary Transthyretin Amyloidosis (HATTR) Revenue
3.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio
3.4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
3.5 Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Area Served
3.6 Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
3.7 Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Type
4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Type (2016-2021)
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2022-2027)

5 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Application
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Application (2016-2021)
5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
6.2.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
6.2.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
6.2.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
6.3.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
6.3.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
6.3.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
6.4 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
6.4.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
6.4.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
7.2.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
7.2.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
7.2.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
7.3.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
7.3.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
7.3.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
7.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
7.4.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
7.4.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
8.2.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
8.3.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
8.4 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region
8.4.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
9.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
9.2.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
9.2.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
9.2.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
9.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
9.3.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
9.3.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
9.3.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
9.4 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
9.4.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
9.4.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2016-2027)
10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
10.2.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2027)
10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
10.3.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2027)
10.4 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
10.4.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.1.4 Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Akcea Therapeutics
11.3.1 Akcea Therapeutics Company Details
11.3.2 Akcea Therapeutics Business Overview
11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.3.4 Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.3.5 Akcea Therapeutics Recent Development
11.4 Prothena
11.4.1 Prothena Company Details
11.4.2 Prothena Business Overview
11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.4.4 Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.4.5 Prothena Recent Development
11.5 Lonis Pharmaceuticals
11.5.1 Lonis Pharmaceuticals Company Details
11.5.2 Lonis Pharmaceuticals Business Overview
11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.5.4 Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.5.5 Lonis Pharmaceuticals Recent Development
11.6 Eidos Therapeutics
11.6.1 Eidos Therapeutics Company Details
11.6.2 Eidos Therapeutics Business Overview
11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.6.4 Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.6.5 Eidos Therapeutics Recent Development
11.7 Corino Therapeutics Inc
11.7.1 Corino Therapeutics Inc Company Details
11.7.2 Corino Therapeutics Inc Business Overview
11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.7.4 Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
11.7.5 Corino Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Subcutaneous Injection
Table 4. Key Players of Others
Table 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2016-2021)
Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2022-2027)
Table 11. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
Table 12. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
Table 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players (2016-2021)
Table 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2020)
Table 18. Ranking of Global Top Hereditary Transthyretin Amyloidosis (HATTR) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
Table 22. Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2016-2021)
Table 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2016-2021)
Table 30. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 65. Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Alnylam Pharmaceuticals Company Details
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 70. Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Development
Table 72. Akcea Therapeutics Company Details
Table 73. Akcea Therapeutics Business Overview
Table 74. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 75. Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 76. Akcea Therapeutics Recent Development
Table 77. Prothena Company Details
Table 78. Prothena Business Overview
Table 79. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 80. Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 81. Prothena Recent Development
Table 82. Lonis Pharmaceuticals Company Details
Table 83. Lonis Pharmaceuticals Business Overview
Table 84. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 85. Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 86. Lonis Pharmaceuticals Recent Development
Table 87. Eidos Therapeutics Company Details
Table 88. Eidos Therapeutics Business Overview
Table 89. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 90. Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 91. Eidos Therapeutics Recent Development
Table 92. Corino Therapeutics Inc Company Details
Table 93. Corino Therapeutics Inc Business Overview
Table 94. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 95. Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021) & (US$ Million)
Table 96. Corino Therapeutics Inc Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Subcutaneous Injection Features
Figure 4. Others Features
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
Figure 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions: 2020 VS 2027
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Regions (2022-2027)
Figure 14. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players in 2020
Figure 15. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2020
Figure 17. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2016-2021)
Figure 18. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2022-2027)
Figure 19. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
Figure 21. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
Figure 22. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
Figure 23. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
Figure 27. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
Figure 28. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
Figure 29. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2016-2027)
Figure 39. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
Figure 47. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
Figure 48. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
Figure 49. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2016-2027)
Figure 55. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 60. Akcea Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 61. Prothena Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 62. Lonis Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 63. Eidos Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 64. Corino Therapeutics Inc Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---